DURHAM – Golden Pine Ventures, a newly formed venture capital firm in RTP is setting up shop to try and find promising biotechnology and biomedical companies.

The company will be led by Christopher S. Meldrum, who will be managing director of the firm. Meldrum recently left his post as Director of Corporate Alliances at Paradigm Genetics.

The Chairman of Golden Pine Ventures is Peter D. Meldrum, and joining him on the Board of Directors are Christopher Meldrum, Dale Stringfellow, John Hamer, and Jim Severson.

Peter Meldrum is currently the President, Chief Executive Officer, and a Director of Myriad Genetics, a publicly-traded biopharmaceutical company.

Dr. Dale Stringfellow is the founder of three biotechnology companies, and is currently Chairman of the Board of Collateral Therapeutics.

Dr. John Hamer is currently Entrepreneur-in-Residence at Burrill & Company, a life sciences merchant bank.

Dr. Jim Severson is the Vice Provost for Intellectual Property and Technology Transfer at the University of Washington.

www.goldenpineventures.com

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2004, TechJournal South. All rights reserved.